Selected evidence synthesis · Human observations, experimental mechanisms, and intervention studies. How we test convergence

The working explanation

Dietary response gives the metal hypothesis a clinical foothold.

A low-nickel dietary pilot reported improvements in gastrointestinal and gynecological symptoms. A large prospective cohort linked red meat and heme iron with endometriosis diagnosis. Alongside evidence of altered local iron handling and microbial inflammatory signals, these findings motivate a connected model of exposure, host response, and microbial function. The scientific opportunity is to identify metal-responsive disease subgroups and explain why changing an input changes symptoms. This is a synthesis of existing findings into testable mechanisms. [1] [2] [3] [4]

What microbial metallomics adds

Microbiome Medicine’s approach brings disease-associated microbial signatures, functional mechanisms, and intervention outcomes into the same explanation. Concordance across those lines of evidence can identify a causal hypothesis before all intermediate steps have been measured in one study. This synthesis develops that approach by treating metal availability and host nutritional immunity as possible organizing variables. [5]

The contribution is a set of mechanistic questions: could nickel sensitivity and nickel-dependent microbial chemistry identify different responders to the same dietary change? Could heme intake and host iron retention help explain a microbial inflammatory niche? Could an intervention alter virulence or inflammatory signaling without eliminating the organism? Those questions connect nutritional epidemiology, microbial physiology, and host metal biology.

Proposed explanatory model. Its individual foundations come from different studies; the connections generate predictions.
  1. An exposure can change

    Dietary nickel reduction has a symptom-intervention signal; red meat and heme iron have prospective disease associations. [1] [2]

  2. The host and microbe respond

    Nickel-sensitive host signaling, organism-specific metal enzymes, and iron redistribution supply defined mechanisms to investigate. [6] [7] [3]

  3. The function predicts response

    A useful model predicts which patients respond and whether metal access, microbial activity, or host signaling changes with that response.

Bradford Hill’s viewpoints and modern triangulation support reasoning across evidence with different sources of bias. Clinical responses contribute to that reasoning even when their mediator is unresolved. Measuring the mediator can then distinguish explanations and improve intervention design. [8] [9]

Low nickel and lower red-meat exposure belong at the center

Low nickel: an exposure-linked clinical signal

Borghini and colleagues studied women with endometriosis and substantial gastrointestinal symptoms. After three months of a low-nickel diet, completers reported reductions in gastrointestinal symptoms, chronic pelvic pain, dysmenorrhea, and dyspareunia; the three gynecological pain outcomes each had P<.005. Of 31 completers, 28 had a positive nickel oral mucosa patch test. The dietary phase enrolled 47 women; 16 withdrew. Its uncontrolled, open-label design limits attribution, but the observed response makes nickel sensitivity and exposure serious candidates for explaining a symptomatic subgroup. [1]

The immune-susceptibility evidence also has a temporal component. Yuk and colleagues found more prior nickel-allergy diagnoses among later endometriosis cases than controls: 8/997 versus 13/3,988, adjusted OR 2.47, 95% CI 1.02–5.99. This establishes the order of recorded diagnoses, rather than disease onset. Together with the dietary response, it makes host nickel sensitivity a concrete phenotype to investigate alongside microbial nickel use. [10]

Read alongside the blood-nickel association and nickel-sensitive host and enzyme chemistry, the pilot supplies a response-to-change observation. A follow-up can ask whether responders show altered metal exposure, host inflammatory signaling, microbial activity, or a combination. A direct host effect and a microbial effect could reinforce each other; discovering their relative contribution is part of the field’s purpose. [11] [6] [7]

Red meat and heme iron: the chemical form matters

Yamamoto and colleagues followed 81,908 Nurses’ Health Study II participants and recorded 3,800 laparoscopically confirmed diagnoses. More than two daily red-meat servings versus at most one weekly serving was associated with higher risk: RR 1.56, 95% CI 1.22–1.99. Heme iron also showed a positive association: highest versus lowest quintile RR 1.30, 95% CI 1.17–1.44. Mutual adjustment attenuated both associations without eliminating them. This makes iron form relevant to the dietary question, while leaving correlated meat constituents and host pathways to distinguish. [2]

Earlier Italian case-control data also associated higher red-meat intake with endometriosis; a US population-based study did not. These comparisons keep replication and exposure range part of the research question. [12] [13]

There is also intervention evidence for a dietary pattern that excluded red meat. In Ott and colleagues’ uncontrolled study of 68 women, a Mediterranean-style regimen changed several food groups and improved reported pain over five months; 43 adhered for the full period. It supports studying diet as a modifiable input, while the combined regimen cannot isolate red-meat reduction or heme iron as the active component. [14]

The proposed metal model has two connected locations to examine: dietary heme exposure in the gut and menstrual iron processing in the pelvis. Host transport and retention connect iron compartments, so dietary intake and local microbial access need to be measured separately. This model predicts that chemical form and compartment will explain more than a total-iron value alone. It also asks whether nickel responsiveness identifies a subgroup rather than assuming every beneficial dietary pattern works through the same metal. [15] [16] [3]

Low-nickel and lower-red-meat diets test different inputs. The endometriosis low-nickel pilot did not isolate red-meat reduction, and a low-nickel H. pylori trial explicitly allowed beef. Food labels therefore cannot stand in for metal composition. A mechanistic dietary study needs to track nickel, heme iron, and the other changed nutrients separately. [1] [17]

Iron matters because the pool and the cell matter

Retrograde menstrual material offers a route by which endometrial cells, heme-containing material, and bacterial products could reach the pelvis together. Human studies found higher peritoneal-fluid iron and ferritin in defined settings and more stored iron in peritoneal macrophages. This makes local metal handling a biological starting point. It does not mean that every patient has high circulating iron or that all detected iron is available to microbes. [15] [16] [4]

A host mechanism supported by human samples and stromal-cell experiments. The microbial consequence is a separate question.
  1. A local signal

    Menstrual hepcidin was higher in one small endometriosis comparison; iron totals did not significantly differ in that study. [3]

  2. A transport change

    Hepcidin reduced ferroportin in stromal cells, limiting iron export and increasing intracellular Fe²⁺. [3]

  3. A functional consequence

    Hepcidin with iron increased reactive oxygen species and inflammatory cytokines in the tested cells. [3]

Nutritional immunity changes distribution. Retaining iron inside a host cell can reduce what an extracellular organism can acquire while changing the resources encountered by an intracellular organism. The proposed microbial explanation therefore needs a location: which organism, outside or inside which cell, using heme, transferrin-bound iron, ferritin-associated iron, or a labile pool? None can be inferred from total iron alone.

Lactoferrin and ferritin also need compartment-specific interpretation. In a paired plasma/peritoneal study, the ferritin ratio distinguished cases from controls, but the lactoferrin ratio did not distinguish all cases; a stage comparison did differ. Concentration is not the same as iron saturation, bacterial access, or demonstrated antimicrobial function. [18]

The metal signature is informative, but not uniform

Selected human findings. Different specimens and populations cannot be pooled as a single high-metal phenotype.
Measured compartmentFindingImplication for the model
Whole-blood nickel; Sri Lanka, 50 cases and 50 controlsGeometric mean nickel 2.6 versus 0.8 µg/L. Lead and cadmium did not differ.A nickel signal worth following; the study did not measure microbial function or establish time order. [11]
Blood and follicular fluid; reproductive-center case-control sample, 609 participantsHigher blood arsenic, cadmium, and lead categories were associated with endometriosis; overlapping fluid subsets also showed selected associations.Supports exposure/handling hypotheses in this setting. Does not establish arsenic-species effects, microbial mediation, or that exposure preceded disease. [19]
Blood and urine; ENDO operative cohort, 473 womenContinuous-element models were null. The highest blood-cadmium category had lower odds; selected urinary copper/chromium categories were positive.Contradicts a universal positive Cd/Pb pattern. Urinary nickel and whole-blood nickel are different measurements. [20]
Peritoneal fluid and macrophagesLocal iron, ferritin, transferrin saturation, and macrophage storage differed in studies of defined populations.A local accessible-pool hypothesis must distinguish stored from available iron and account for cycle phase. [15] [16]
Menstrual blood and cultured host stromal cellsHigher hepcidin, with intracellular iron retention after a mechanistic perturbation.A redistribution mechanism can operate without a higher bulk-fluid iron total. [3]

The inference should explain the discordance as well as the positive findings. Geography, fertility-clinic selection, disease phenotype, cycle phase, exposure timing, and specimen type can alter the comparison. They are variables to measure, not automatic explanations that rescue a favored hypothesis.

Which microbial signal occurs in which compartment?

Khan and colleagues found more E. coli colony formation in menstrual samples and higher endotoxin in menstrual and peritoneal fluid. This supports a local bacterial-product hypothesis. Menstrual fluid is not peripheral bloodstream bacteremia; the finding does not establish bacteria surviving unrecognized in the circulation. [4]

Muraoka and colleagues supplied a stronger model-level connection: Fusobacterium enrichment in an ovarian-endometriosis-focused human cohort, TGF-β-linked conversion toward TAGLN-positive myofibroblast behavior, and antibiotic-responsive lesions in mice. This is a partial triangle connecting an organism, host mechanism, and intervention response. The metal dependence of that route was not measured. [21]

Talwar and colleagues offer a positive functional example. In 18 women with endometriosis and 31 controls, stool 4-hydroxyindole (4HI) was lower in cases, with targeted analysis confirming the finding. Administering 4HI reduced lesions, inflammation, and mechanical hypersensitivity in mice; benefits also appeared in established-lesion models and xenografts made with immortalized human endometriotic cells. This connects a human metabolite signature with an intervention and a disease phenotype. The work supports the proposed direction of research while leaving human therapeutic benefit and metal mediation open. [22]

The signature must survive replication and respect the sampled niche.
Primary comparisonResultWhat this changes
Independent eutopic-endometrium qPCR; 55 cases, 37 controlsNo significant case–control Fusobacterium enrichment, including severity-stratified comparisons.The earlier signal cannot be treated as a universal marker. Subtype and sampling hypotheses need prospective tests. [23]
Estonian stool metagenomics; 136 cases, 864 controlsNo significant taxonomic, functional-pathway, diversity, or estrobolome differences after multiple-testing adjustment.A broad fecal signature is not assured. This does not exclude a local pelvic process or a defined active-disease subgroup. [24]
Low-biomass pelvic sampling with negative controls; 18 cases, 18 controlsNo specific peritoneal or ovarian-cyst-fluid community after accounting for background.Sequence detection must be compared with procedural background. Transient bacterial products remain a different possibility. [25]
Small endometrial sequencing study; 12 cases, 9 symptomatic controlsDifferences included both Gram-positive and Gram-negative taxa; other Gram-negative taxa favored controls.Do not substitute a universal Gram-negative bloom for strain-resolved measurement. [26]

A useful disease signature need not occur in every patient. It must identify the subgroup and location in which its proposed functions are present, active, and relevant. Absolute abundance, viability, microbial products, and host response answer different parts of that question.

Nickel can connect microbial products with host responsiveness

Nickel offers two potentially interacting routes into the model: effects on microbial functions and effects on the host response to microbial products. Schmidt and colleagues showed that nickel ions can activate human TLR4, a receptor involved in sensing LPS. Nickel recognition differed from LPS recognition, and ordinary mouse TLR4 did not respond in the same way. [6]

Oblak and colleagues found nickel–LPS synergy in cells. This adds a specific explanation for a nickel-responsive inflammatory subgroup: a given bacterial-product exposure could provoke a larger host response when nickel is present. The experiments establish receptor biology; its contribution in endometriosis is a disease-specific question. [27]

The resulting predictions differ but can coexist. A microbial route predicts altered microbial activity or endotoxin with nickel exposure. A host-response route predicts altered inflammatory responsiveness even with similar microbial abundance. Comparing both routes could help explain the reported dietary responses and identify which response markers to follow.

The glyoxalase idea has a biochemical foothold

E. coli provides a verified nickel-activated glyoxalase example. Its glyoxalase I was optimally activated by nickel in biochemical experiments. Glyoxalase helps process the glutathione adduct of methylglyoxal, a reactive carbonyl compound. This supplies a concrete candidate link between metal availability and microbial carbonyl defense. [7]

A separate study established that group B Streptococcus glyoxalase A contributes to methylglyoxal tolerance, resistance to neutrophil killing, and survival in mouse blood. Its nickel dependence remained unresolved. Putative nickel-transport annotations did not settle cofactor identity. Group B Streptococcus is Gram-positive, so it cannot also provide an LPS arm of the explanation. [28]

Together these findings justify asking whether nickel-supported carbonyl defense matters in an endometriosis-associated organism. They do not demonstrate that link in the same strain or tissue. Resistance to immune killing is also different from failure of immune recognition, and bloodstream persistence is not established here as a defining feature of endometriosis.

Low oxygen does not uniquely identify fermentation. In an inflamed-gut model, host-derived nitrate supported E. coli through anaerobic respiration. In endometriosis, enhanced glycolysis and lactate production have been measured in host peritoneal mesothelial cells. Host lactate therefore cannot be assigned to bacterial metabolism without further evidence. [29] [30]

The direction of metabolic intervention matters too. The microbial fermentation product n-butyrate reduced lesion growth in mouse models and growth of human endometriotic cells. The useful objective is to change a harmful function in a defined niche, while preserving functions that restrain inflammation or competitors. [31]

The wider dietary pattern can refine the metal explanation

The prospective Nurses’ Health Study II analysis included 70,835 women and 2,609 laparoscopically confirmed incident cases. At least one daily serving of citrus, including citrus juices, was associated with lower risk than less than one weekly serving: RR 0.78, 95% CI 0.69–0.89. Cruciferous vegetables showed a positive trend, but the extreme-category estimate was less precise: RR 1.13, 95% CI 0.95–1.34. Total vegetable intake was not associated with risk. [32]

The opposing food associations give a metal model a pattern to explain. Nickel hyperaccumulation in particular Brassicaceae, including Streptanthus polygaloides, establishes that plant chemistry can vary markedly. To connect this with ordinary cruciferous foods, the useful test is measured edible-tissue nickel and individual exposure alongside fiber, glucosinolates, preparation, and other constituents. The original diet study measured food intake rather than nickel or microbial mediation. [32] [33]

Smoking also needs a time window. An ENDO analysis using presurgical cotinine found no adult-smoking association after adjustment: RR 1.0, 95% CI 0.7–1.6. A Swedish birth cohort instead found associations with maternal smoking during pregnancy. These do not support one interchangeable smoking signal or identify nickel, cadmium, lead, or microbes as its mediator. [34] [35]

Citrus and crucifer findings came from the same underlying Nurses’ Health Study II as the red-meat analysis; they broaden the dietary comparison rather than independently replicate it. Together they motivate a chemically specified dietary hypothesis: track which metal forms and microbial substrates actually change, then ask which changes predict symptoms or disease risk. [32] [2]

Does changing the system improve the disease?

Disease-specific intervention results: what changed, and whether the proposed mechanism was measured.
Intervention and studyDisease outcomeWhat the result can triangulate
Low-nickel diet; three-month open-label pilotGastrointestinal symptoms, chronic pelvic pain, dysmenorrhea, and dyspareunia improved among completers.Provides a clinical response signal for investigating a nickel-responsive subgroup. Its uncontrolled design and absent mediator measurements leave the route of benefit to resolve; participant flow is detailed above. [1]
Mediterranean-style diet excluding red meat; uncontrolled five-month studyReported pain improved; 43 of 68 women adhered for the full period.A dietary intervention signal consistent with modifiable inputs. Multiple foods changed, so the response does not identify a heme-specific effect. [14]
Heat-killed L. gasseri OLL2809; small randomized placebo-controlled trialMenstrual pain and dysmenorrhea improved over 12 weeks.Supports a symptom signal. Heat-killed bacteria cannot establish live competition, colonization, or acidification; host immune mediation was proposed, not demonstrated in the trial. [36]
L. salivarius CECT 30632; 2026 randomized pilot, 37 women receiving dienogestReported pain/quality-of-life and estradiol changes; overall vaginal diversity did not differ.A named strain with estrogen-metabolizing activity and an adjunct clinical signal. Metal mediation and pathogen displacement were not established. [37]
Postoperative metronidazole; METROFERT randomized trial88 randomized, 72 in the final cohort; pain persistence at six weeks was 84% versus 88%, P=.74.No significant benefit in this setting. Mouse antibiotic lesion findings do not close the human clinical triangle. The trial does not resolve an organism-selected subgroup with documented target engagement. [38]

An intervention can improve pain while leaving lesion burden or the proposed microbial pathway unchanged. Those are different outcomes. Likewise, a negative postoperative pain trial weighs against that regimen’s expected benefit without proving that every microbial mechanism is absent. The next clinical claim should specify the phenotype, mediator, and endpoint in advance.

Interventions can test several different microbial vulnerabilities

The examples below explain how the framework can work. They are evidence from their named systems; none supplies a complete endometriosis clinical mechanism. Killing, reducing virulence, changing resource access, and altering host signaling are different effects and should be recorded separately.

A clinical precedent for dietary metal restriction and microbial treatment

H. pylori supplies a relevant nickel-dependent microbial precedent. Campanale and colleagues’ randomized pilot added a low-nickel diet to antibiotic treatment and reported eradication in 22/26 participants versus 12/26 with antibiotics alone. A later randomized study by Brito and colleagues, which excluded nickel allergy, found higher eradication among protocol completers (91.7% versus 75.8%); its intention-to-treat comparison was not statistically significant (76.4% versus 66.2%, P=.199). These trials give dietary metal restriction a human microbial-treatment rationale. They test an adjunct to antibiotics in gastric infection; they do not identify the organism or route behind the endometriosis dietary response. [39] [17]

This precedent changes the research question from whether a dietary metal could matter at all to where, for whom, and through which process it matters. Endometriosis research can compare nickel-sensitive immune responses with metal-dependent microbial activity, using the reported symptom response to select informative hypotheses.

Fungal interactions now have a disease-specific foothold. Talwar and colleagues found altered gut fungal–bacterial co-abundance patterns in women with endometriosis; fungal depletion reduced disease progression in mice. This supports investigating community interactions. It does not yet identify Candida shielding a named pathogen in pelvic lesions, metal mediation, or a human antifungal benefit. [40]

Mechanistic precedents and the disease-specific bridge still needed.
Function targetedDemonstrated exampleWhat endometriosis research would need
Compete for a metalE. coli Nissle 1917 restricted Salmonella through iron acquisition in a mouse gut model, with the lipocalin-2 environment affecting competition.The relevant strain and accessible metal pool in the affected niche, followed by a disease outcome. [41]
Interfere with a competitorEcN microcins contributed to competition among Enterobacteriaceae in the inflamed mouse gut.For a prebiotic claim, evidence that its substrate supports this producer and function—not just a higher taxon abundance. [42]
Reduce virulence without killingS. boulardii products, including capric acid, reduced Candida filamentation, adhesion, and biofilm formation in culture.Presence and causal relevance of the fungal partner; an in-vivo effect on the proposed microbial interaction. [43]
Remove protection supplied by another speciesA Candida biofilm matrix increased S. aureus antimicrobial tolerance in a mixed-biofilm model.Evidence of that partnership in endometriosis. Protection from an antimicrobial is not automatically concealment from immune recognition. [44]
Change local acidityMicrobial short-chain fatty acids inhibited Enterobacteriaceae through intracellular acidification in the proximal-colon context.The actual site, metabolites, pH, and target response; a specific intervention and clinical endpoint. [45]
Alter signaling and virulence outputBerberine inhibited Pseudomonas quorum-sensing outputs in experimental work implicating PqsR.The same target and relevant exposure in endometriosis; benefits elsewhere do not identify this mechanism here. [46]
Test a terpene’s route of actionThymol affected estrogen signaling, inflammatory responses, and endometriosis progression in mouse and Ishikawa-cell experiments.A microbial mechanism must be distinguished from the observed direct host effects, then connected to a human outcome. [47]

The research program: explain response through metal-dependent functions

Human exposure + dietary response + mechanistic foundations

A nickel-responsive subgroup is a substantive research target.

Blood-nickel and prior-allergy associations, symptom changes during a low-nickel diet, and nickel-sensitive host signaling give this model several points of support. [11] [1] [6] [27] [10]

Research direction. Compare how nickel exposure, host responsiveness, and microbial function track symptom response; distinguish immune and microbial contributions.

Dietary association + local host mechanism

Iron form and routing could connect diet to disease biology.

The heme-iron association adds a dietary dimension to local iron storage and hepcidin–ferroportin biology. [2] [16] [3]

Research direction. Determine whether dietary heme, gut function, and pelvic iron handling covary in the relevant subgroup; separate intake from the iron pool available to a microbe.

Human observations + host-cell mechanism

Local iron redistribution can amplify inflammation.

Peritoneal iron storage and the hepcidin–ferroportin mechanism give this part of the model a direct biological foundation. [16] [3]

Research direction. Test whether microbial iron-acquisition activity and inflammation differ with host iron retention in the affected compartment.

Human signature + preclinical intervention

A depleted microbial metabolite can identify a functional intervention.

Lower stool 4HI in the human comparison led to supplementation that improved several disease-related outcomes in mouse models. [22]

Research direction. Follow the relevant metabolite producers and host response in independent human populations, and test clinical effects; metal mediation is an additional research question.

Partial convergence; human replication differs

A defined microbe can change endometrial cell behavior.

Fusobacterium–TGF-β work connects organism, host phenotype, and animal intervention; a later human cohort did not reproduce enrichment. [21] [23]

Research direction. Identify the disease subgroup in which organism, host-cell response, and intervention outcome align; assess whether metal availability explains that alignment.

Mechanistically plausible; cross-study bridge open

Nickel-supported carbonyl defense could affect microbial persistence.

E. coli nickel-activated glyoxalase and GBS glyoxalase-dependent survival establish different parts of a possible relationship. [7] [28]

Research direction. Determine whether the same disease-associated organism expresses a nickel-supported carbonyl-defense function in the relevant compartment.

Host–microbial interaction demonstrated in cells

Nickel sensitivity could amplify the effect of existing microbial products.

Human TLR4 activation and nickel–LPS synergy provide a route by which metal exposure and bacterial products could interact. [6] [27]

Research direction. Assess whether nickel-associated host responsiveness predicts symptoms or dietary response independently of microbial abundance.

The field advances when an intervention result becomes a mechanistic clue: which input changed, which function responded, and which patients benefited? Connecting those observations can identify an actionable resource constraint, a host-sensitivity phenotype, or a microbial vulnerability. The present evidence supplies several starting points for that work.

Questions worth asking

What is this synthesis intended to contribute?

It organizes existing dietary, metal, microbial, and host-defense findings into explanations that predict different intervention responses. Its contribution is a mechanistic research agenda: define metal-responsive subgroups, identify the affected functions, and select measurements that distinguish them. It reports no new patient experiment and does not require every intermediate to be settled before a grounded hypothesis is useful.

Does endometriosis have one established microbiome signature?

Published findings vary with the compartment, population, disease phenotype, and analytical method. Local bacterial-product and organism-specific results coexist with larger null stool studies and non-replication. A useful signature must specify its setting and be tested independently.

Does elevated iron mean pathogens have more iron to use?

Only if the relevant chemical pool is accessible to the organism. Ferritin storage, heme, intracellular retention, protein binding, and extracellular labile iron are different resources. A bulk measurement does not identify which is available.

What does improvement on a low-nickel diet contribute to the hypothesis?

It adds a human response-to-intervention observation to nickel exposure and mechanistic findings. The pilot reported gastrointestinal and gynecological symptom improvement in a selected group. Explaining that response through host sensitivity, microbial function, or both is a concrete research objective; its uncontrolled design leaves causal attribution open.

Must mechanistic research wait for randomized trials?

No. A grounded mechanism and a discriminating prediction are useful before a definitive trial. The type of conclusion must match the evidence: a promising causal model, a demonstrated model mechanism, and a proven clinical effect are different claims.

Follow the connections

Sources & further reading

Primary studies and methodological sources supporting the linked statements; the originating framework is credited separately. The framework and proposed experiments are editorial synthesis, not a clinical guideline or a systematic review.

  1. Borghini R et al. (2020). Irritable Bowel Syndrome-Like Disorders in Endometriosis: Prevalence of Nickel Sensitivity and Effects of a Low-Nickel Diet. An Open-Label Pilot Study. View source↩↩↩↩↩↩
  2. Yamamoto A, Harris HR, Vitonis AF, Chavarro JE, Missmer SA (2018). A prospective cohort study of meat and fish consumption and endometriosis risk. View source↩↩↩↩↩
  3. Izumi Y et al. (2023). Hepcidin as a key regulator of iron homeostasis triggers inflammatory features in the normal endometrium. View source↩↩↩↩↩↩↩↩↩
  4. Khan KN et al. (2010). Escherichia coli contamination of menstrual blood and effect of bacterial endotoxin on endometriosis. View source↩↩↩
  5. Pendergrass K, Eyer K, Aleru D, Aristotelous G (2025). Endometriosis — Microbiome Medicine. View source↩
  6. Schmidt M et al. (2010). Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel. View source↩↩↩↩↩
  7. Clugston SL et al. (1998). Overproduction and characterization of a dimeric non-zinc glyoxalase I from Escherichia coli: evidence for optimal activation by nickel ions. View source↩↩↩↩
  8. Hill AB (1965). The Environment and Disease: Association or Causation?. View source↩
  9. Lawlor DA, Tilling K, Davey Smith G (2016). Triangulation in aetiological epidemiology. View source↩
  10. Yuk JS, Shin JS, Shin JY, Oh E, Kim H, Park WI (2015). Nickel Allergy Is a Risk Factor for Endometriosis: An 11-Year Population-Based Nested Case-Control Study. View source↩↩
  11. Silva N, Senanayake H, Waduge V (2013). Elevated levels of whole blood nickel in a group of Sri Lankan women with endometriosis: a case control study. View source↩↩↩
  12. Parazzini F et al. (2004). Selected food intake and risk of endometriosis. View source↩
  13. Trabert B, Peters U, De Roos AJ, Scholes D, Holt VL (2011). Diet and risk of endometriosis in a population-based case–control study. View source↩
  14. Ott J, Nouri K, Hrebacka D, Gutschelhofer S, Huber JC, Wenzl R (2012). Endometriosis and nutrition – recommending a Mediterranean diet decreases endometriosis-associated pain: an experimental observational study. View source↩↩
  15. Van Langendonckt A, Casanas-Roux F, Donnez J (2002). Iron overload in the peritoneal cavity of women with pelvic endometriosis. View source↩↩↩
  16. Lousse JC et al. (2009). Iron storage is significantly increased in peritoneal macrophages of endometriosis patients and correlates with iron overload in peritoneal fluid. View source↩↩↩↩↩
  17. Brito BS, de Souza FFR, Baptista DM, Lages RB, Barbuti RC, Navarro-Rodriguez T (2025). Low-nickel diet as a strategy in the treatment of Helicobacter pylori infection. View source↩↩
  18. Skarżyńska E et al. (2023). The Influence of Lactoferrin in Plasma and Peritoneal Fluid on Iron Metabolism in Women with Endometriosis. View source↩
  19. Shen L et al. (2023). The association between exposure to multiple toxic metals and the risk of endometriosis: Evidence from the results of blood and follicular fluid. View source↩
  20. Pollack AZ et al. (2013). Trace elements and endometriosis: the ENDO study. View source↩
  21. Muraoka A et al. (2023). Fusobacterium infection facilitates the development of endometriosis through the phenotypic transition of endometrial fibroblasts. View source↩↩
  22. Talwar C et al. (2025). Identification of distinct stool metabolites in women with endometriosis for non-invasive diagnosis and potential for microbiota-based therapies. View source↩↩
  23. Graciano-España MC et al. (2025). Fusobacterium nucleatum is not significantly present in eutopic endometrium from patients with minimal-mild and moderate-severe endometriosis. View source↩↩
  24. Pérez-Prieto I et al. (2024). Gut microbiome in endometriosis: a cohort study on 1000 individuals. View source↩
  25. Oishi S et al. (2022). Microbiome analysis in women with endometriosis: Does a microbiome exist in peritoneal fluid and ovarian cystic fluid?. View source↩
  26. Wessels JM et al. (2021). Endometrial microbiota is more diverse in people with endometriosis than symptomatic controls. View source↩
  27. Oblak A, Pohar J, Jerala R (2015). MD-2 Determinants of Nickel and Cobalt-Mediated Activation of Human TLR4. View source↩↩↩
  28. Akbari MS et al. (2025). Identification of glyoxalase A in group B Streptococcus and its contribution to methylglyoxal tolerance and virulence. View source↩↩
  29. Winter SE et al. (2013). Host-derived nitrate boosts growth of E. coli in the inflamed gut. View source↩
  30. Horne AW et al. (2019). Repurposing dichloroacetate for the treatment of women with endometriosis. View source↩
  31. Chadchan SB et al. (2021). Gut microbiota–derived short-chain fatty acids protect against the progression of endometriosis. View source↩
  32. Harris HR, Eke AC, Chavarro JE, Missmer SA (2018). Fruit and vegetable consumption and risk of endometriosis. View source↩↩↩
  33. Jhee EM, Boyd RS, Eubanks MD (2005). Nickel hyperaccumulation as an elemental defense of Streptanthus polygaloides (Brassicaceae): influence of herbivore feeding mode. View source↩
  34. Hemmert R et al. (2019). Modifiable life style factors and risk for incident endometriosis. View source↩
  35. Gao M, Scott K, Koupil I (2020). Associations of perinatal characteristics with endometriosis: a nationwide birth cohort study. View source↩
  36. Itoh H et al. (2011). Lactobacillus gasseri OLL2809 is effective especially on the menstrual pain and dysmenorrhea in endometriosis patients: randomized, double-blind, placebo-controlled study. View source↩
  37. Jara J et al. (2026). Probiotic supplementation improves quality of life and modulates oestradiol in women with endometriosis: a randomised double-blind pilot trial. View source↩
  38. Quevedo A et al. (2025). The impact of metronidazole on pain persistence after fertility-sparing endometriosis surgery: METROFERT randomized study. View source↩
  39. Campanale M et al. (2014). Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study. View source↩
  40. Talwar C et al. (2025). A role for gut mycobiome and altered fungal–bacterial interactions in women with endometriosis. View source↩
  41. Deriu E et al. (2013). Probiotic Bacteria Reduce Salmonella Typhimurium Intestinal Colonization by Competing for Iron. View source↩
  42. Sassone-Corsi M et al. (2016). Microcins mediate competition among Enterobacteriaceae in the inflamed gut. View source↩
  43. Murzyn A et al. (2010). Capric acid secreted by S. boulardii inhibits C. albicans filamentous growth, adhesion and biofilm formation. View source↩
  44. Kong EF et al. (2016). Commensal Protection of Staphylococcus aureus against Antimicrobials by Candida albicans Biofilm Matrix. View source↩
  45. Sorbara MT et al. (2019). Inhibiting antibiotic-resistant Enterobacteriaceae by microbiota-mediated intracellular acidification. View source↩
  46. Ning W et al. (2026). Berberine: A Natural pqs System Inhibitor in Pseudomonas aeruginosa for Foodborne Infection Control. View source↩
  47. Zhang Y et al. (2024). Thymol Impacts the Progression of Endometriosis by Disrupting Estrogen Signaling Pathways and Inflammatory Responses. View source↩
Cite this page

Karen Pendergrass. Endometriosis at the metal–microbe–immune interface. 2026-10-02. https://microbialmetallomics.com/library/endometriosis-metals-microbiome